Guideline summary : appropriate use of tigecycline
| dc.contributor.author | Brink, Adrian J. | |
| dc.contributor.author | Bizos, D. | |
| dc.contributor.author | Boffard, Kenneth D. | |
| dc.contributor.author | Feldman, Charles | |
| dc.contributor.author | Grolman, D.C. | |
| dc.contributor.author | Pretorius, J. | |
| dc.contributor.author | Richards, Guy A. | |
| dc.contributor.author | Steyn, E. | |
| dc.date.accessioned | 2012-03-30T06:25:04Z | |
| dc.date.available | 2012-03-30T06:25:04Z | |
| dc.date.issued | 2012-02 | |
| dc.description.abstract | Tigecycline, the first of a new class of broad-spectrum antibiotics (the glycylcyclines), has been licensed in South Africa for the parenteral treatment of adult patients with complicated intra-abdominal infections (cIAIs) and complicated skin and soft-tissue infections (cSSTIs). | en_US |
| dc.description.uri | http://www.hmpg.co.za/journaldetail.php?journalno=8 | en_US |
| dc.identifier.citation | Brink, AJ, Bizos, D, Boffard, KD, Feldman, C, Grolman, DC, Pretorius, J, Richards, GA & Steyn, E 2012, 'Guideline summary : appropriate use of tigecycline', South African Journal of Surgery, vol. 50, no. 1, pp. 20-21. | en_US |
| dc.identifier.issn | 0038-2361 (print) | |
| dc.identifier.issn | 2078-5151 (online) | |
| dc.identifier.uri | http://hdl.handle.net/2263/18524 | |
| dc.language.iso | en | en_US |
| dc.publisher | Health and Medical Publishing Group | en_US |
| dc.rights | Health and Medical Publishing Group | en_US |
| dc.subject | Tigecycline | en_US |
| dc.subject | Directed combination therapy | en_US |
| dc.subject | Directed monotherapy | en_US |
| dc.subject | Empiric monotherapy | en_US |
| dc.title | Guideline summary : appropriate use of tigecycline | en_US |
| dc.type | Article | en_US |